메뉴 건너뛰기
Communicative and Integrative Biology
Volumn 6, Issue 5, 2013, Pages
GSK-3 and lysosomes meet in Alzheimer's disease
Author keywords

A pathology; Alzheimer's disease; GSK 3; Lysosome; Presenilin 1
Indexed keywords

EID: 84884697354     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.25179     Document Type: Article
Times cited : (7)
References (18)
  • 1
    • 84863482530 scopus 로고    scopus 로고
    • Lysosomal function and dysfunction: mechanism and disease
    • PMID:22098160
    • Boya P. Lysosomal function and dysfunction: mechanism and disease. Antioxid Redox Signal 2012; 17:766-74; PMID:22098160; http://dx.doi.org/10.1089/ars.2011.4405
    • (2012) Antioxid Redox Signal , vol.17 , pp. 766-74
    • Boya, P.1
  • 2
    • 79959979604 scopus 로고    scopus 로고
    • Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis
    • PMID:21464620
    • Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, et al. Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy 2011; 7:788-9; PMID:21464620; http://dx.doi.org/10.4161/auto.7.7.15596
    • (2011) Autophagy , vol.7 , pp. 788-9
    • Yang, D.S.1    Stavrides, P.2    Mohan, P.S.3    Kaushik, S.4    Kumar, A.5    Ohno, M.6
  • 3
    • 79958694159 scopus 로고    scopus 로고
    • Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models
    • PMID:21695208
    • Butler D, Hwang J, Estick C, Nishiyama A, Kumar SS, Baveghems C, et al. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS ONE 2011; 6:e20501; PMID:21695208; http://dx.doi.org/10.1371/journal.pone.0020501
    • (2011) PLoS ONE , vol.6
    • Butler, D.1    Hwang, J.2    Estick, C.3    Nishiyama, A.4    Kumar, S.S.5    Baveghems, C.6
  • 4
    • 53849106834 scopus 로고    scopus 로고
    • Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease
    • PMID:18957217
    • Sun B, Zhou Y, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, et al. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 2008; 60:247-57; PMID:18957217; http://dx.doi.org/10.1016/j.neuron.2008.10.001
    • (2008) Neuron , vol.60 , pp. 247-57
    • Sun, B.1    Zhou, Y.2    Halabisky, B.3    Lo, I.4    Cho, S.H.5    Mueller-Steiner, S.6
  • 5
    • 0034113064 scopus 로고    scopus 로고
    • When lysosomes get old
    • PMID:10767573
    • Cuervo AM, Dice JF. When lysosomes get old. Exp Gerontol 2000; 35:119-31; PMID:10767573; http://dx.doi.org/10.1016/S0531-5565(00)00075-9
    • (2000) Exp Gerontol , vol.35 , pp. 119-31
    • Cuervo, A.M.1    Dice, J.F.2
  • 6
    • 0035066332 scopus 로고    scopus 로고
    • Alzheimer's disease: genes, proteins, and therapy
    • PMID:11274343
    • Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741-66; PMID:11274343
    • (2001) Physiol Rev , vol.81 , pp. 741-66
    • Selkoe, D.J.1
  • 7
    • 77951060145 scopus 로고    scopus 로고
    • Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process
    • PMID:20393191
    • De Strooper B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 2010; 90:465-94; PMID:20393191; http://dx.doi.org/10.1152/physrev.00023.2009
    • (2010) Physiol Rev , vol.90 , pp. 465-94
    • De Strooper, B.1
  • 8
    • 55749106048 scopus 로고    scopus 로고
    • The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease
    • PMID:18955053
    • Hernández F, Avila J. The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease. FEBS Lett 2008; 582:3848-54; PMID:18955053; http://dx.doi.org/10.1016/j.febslet.2008.10.026
    • (2008) FEBS Lett , vol.582 , pp. 3848-54
    • Hernández, F.1    Avila, J.2
  • 9
    • 40449098952 scopus 로고    scopus 로고
    • Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice
    • PMID:18258852
    • Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, et al. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 2008; 172:786-98; PMID:18258852; http://dx.doi.org/10.2353/ajpath.2008.070904
    • (2008) Am J Pathol , vol.172 , pp. 786-98
    • Terwel, D.1    Muyllaert, D.2    Dewachter, I.3    Borghgraef, P.4    Croes, S.5    Devijver, H.6
  • 10
    • 33947597084 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics
    • PMID:16944320
    • Jope RS, Yuskaitis CJ, Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 2007; 32:577-95; PMID:16944320; http://dx.doi.org/10.1007/s11064-006-9128-5
    • (2007) Neurochem Res , vol.32 , pp. 577-95
    • Jope, R.S.1    Yuskaitis, C.J.2    Beurel, E.3
  • 11
    • 84857429142 scopus 로고    scopus 로고
    • GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
    • PMID:22065134
    • Eldar-Finkelman H, Martinez A. GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS. Front Mol Neurosci 2011; 4:32; PMID:22065134; http://dx.doi.org/10.3389/fnmol.2011.00032
    • (2011) Front Mol Neurosci , vol.4 , pp. 32
    • Eldar-Finkelman, H.1    Martinez, A.2
  • 12
    • 0038187674 scopus 로고    scopus 로고
    • GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides
    • PMID:12761548
    • Phiel CJ, Wilson CA, Lee VM, Klein PS. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003; 423:435-9; PMID:12761548; http://dx.doi.org/10.1038/nature01640
    • (2003) Nature , vol.423 , pp. 435-9
    • Phiel, C.J.1    Wilson, C.A.2    Lee, V.M.3    Klein, P.S.4
  • 13
    • 33749521100 scopus 로고    scopus 로고
    • Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation
    • PMID:17021169
    • Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26:10129-40; PMID:17021169; http://dx.doi.org/10.1523/JNEUROSCI.1202-06.2006
    • (2006) J Neurosci , vol.26 , pp. 10129-40
    • Oakley, H.1    Cole, S.L.2    Logan, S.3    Maus, E.4    Shao, P.5    Craft, J.6
  • 14
    • 84872351818 scopus 로고    scopus 로고
    • Inhibition of GSK-3 Ameliorates beta-Amyloid(A-beta) Pathology and Restores Lysosomal Acidification and mTOR Activity in the Alzheimer's Disease Mouse Model
    • PMID:23155049
    • Avrahami L, Farfara D, Shaham-Kol M, Vassar R, Frenkel D, Eldar-Finkelman H. Inhibition of GSK-3 Ameliorates beta-Amyloid(A-beta) Pathology and Restores Lysosomal Acidification and mTOR Activity in the Alzheimer's Disease Mouse Model. In vivo and In vitro Studies. J Biol Chem 2013; 288:1295-306; PMID:23155049; http://dx.doi.org/10.1074/jbc.M112.409250
    • (2013) In vivo and In vitro Studies. J Biol Chem , vol.288 , pp. 1295-306
    • Avrahami, L.1    Farfara, D.2    Shaham-Kol, M.3    Vassar, R.4    Frenkel, D.5    Eldar-Finkelman, H.6
  • 15
    • 77953913051 scopus 로고    scopus 로고
    • Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations
    • PMID:20541250
    • Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, PeterhoffCM, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010; 141:1146-58; PMID:20541250; http://dx.doi.org/10.1016/j.cell.2010.05.008
    • (2010) Cell , vol.141 , pp. 1146-58
    • Lee, J.H.1    Yu, W.H.2    Kumar, A.3    Lee, S.4    Mohan, P.S.5    Peterhoff, C.M.6
  • 16
    • 0037444574 scopus 로고    scopus 로고
    • gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation
    • PMID:12584255
    • Herreman A, Van Gassen G, Bentahir M, Nyabi O, Craessaerts K, Mueller U, et al. gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci 2003; 116:1127-36; PMID:12584255; http://dx.doi.org/10.1242/jcs.00292
    • (2003) J Cell Sci , vol.116 , pp. 1127-36
    • Herreman, A.1    Van Gassen, G.2    Bentahir, M.3    Nyabi, O.4    Craessaerts, K.5    Mueller, U.6
  • 17
    • 84873802341 scopus 로고    scopus 로고
    • Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
    • PMID:23202730
    • Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, et al. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 2013; 123:224-35; PMID:23202730; http://dx.doi.org/10.1172/JCI64516
    • (2013) J Clin Invest , vol.123 , pp. 224-35
    • Ly, P.T.1    Wu, Y.2    Zou, H.3    Wang, R.4    Zhou, W.5    Kinoshita, A.6
  • 18
    • 84868687820 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein
    • PMID:22927642
    • Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Mol Cell Biol 2012; 32:4410-8; PMID:22927642; http://dx.doi.org/10.1128/MCB.00930-12
    • (2012) Mol Cell Biol , vol.32 , pp. 4410-8
    • Parr, C.1    Carzaniga, R.2    Gentleman, S.M.3    Van Leuven, F.4    Walter, J.5    Sastre, M.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.